Antinuclear Antibody Test Market Research Report with Latest Trend and Opportunities For $1,476.1 Million Industry

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this ANA testing market.

ID: 1554532
recent pressrelease next pressrelease

(businesspress24) - The Research Report on Antinuclear Antibody Test Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the market, along with revenue estimates & forecasts and market share analysis.

The assay kits & reagents segment is expected to account for the largest share of the global market. The growth in this segment can majorly be attributed to the growth in the number of reagent rental agreements and increasing prevalence of autoimmune diseases.

According to Latest Market research report Published by MarketsandMarkets the

Download PDF Brochure:

Target Audience for this Report:

key players operating in the Global Antinuclear Antibody Test Market;

The major players in this market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Alere Inc. (U.S.) is the second-largest player in the global ANA testing market, with a share of 15.6%. Alere operates in more than 100 countries across the globe, including the U.S., Austria, Denmark, China, Brazil, Indonesia, South Africa, and Japan. The company focuses on new product launches to strengthen its portfolio in the market.

Major Drivers Impacting the Antinuclear Antibody Test Market;

Global ANA Testing Market Segmentation:

Based on techniques, the Antinuclear Antibody Test Market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market due to the expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.

The end user segments in the market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share of the global market. Growth in this segment can be attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, primarily due to easy access to reports and smooth logistics.

Request Research Sample Pages (Please provide your specific interest in this report so as to help you better):

Based on region, the global antinuclear antibody test market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases.

More information:

Keywords (optional):

Company information / Profile:

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

PressRelease by


Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

PressContact / Agency:

published by: gajanan
print pressrelease  send to a friend  

Date: 12/06/2019 - 00:38
Language: English
News-ID 1554532
Character count: 3885
Firma: marketsandmarkets
Ansprechpartner: shelly singh Feedback to about Pressrelease-id:
Stadt: northbook
Telefon: 18886006441

Meldungsart: Financial
Versandart: send
Freigabedatum: 06.12.2019

Number of hits: 716


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 54

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.